BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $990 | -71.1% | 1,000,000 | -71.4% | 0.00% | -66.7% |
Q1 2024 | $3,431 | -0.3% | 3,500,000 | 0.0% | 0.01% | -10.0% |
Q4 2023 | $3,441 | +0.6% | 3,500,000 | 0.0% | 0.01% | 0.0% |
Q3 2023 | $3,420 | -0.5% | 3,500,000 | 0.0% | 0.01% | -9.1% |
Q2 2023 | $3,438 | -2.9% | 3,500,000 | 0.0% | 0.01% | -8.3% |
Q1 2023 | $3,541 | -5.7% | 3,500,000 | 0.0% | 0.01% | -7.7% |
Q4 2022 | $3,755 | -99.9% | 3,500,000 | 0.0% | 0.01% | -7.1% |
Q3 2022 | $3,532,000 | -95.0% | 3,500,000 | -16.2% | 0.01% | -94.8% |
Q2 2022 | $70,578,000 | +1924.6% | 4,175,000 | +19.3% | 0.27% | +2141.7% |
Q1 2022 | $3,486,000 | -95.3% | 3,500,000 | -16.2% | 0.01% | -95.2% |
Q4 2021 | $74,141,000 | +1.6% | 4,175,000 | 0.0% | 0.25% | -8.5% |
Q3 2021 | $72,948,000 | -0.9% | 4,175,000 | 0.0% | 0.27% | +3.4% |
Q2 2021 | $73,603,000 | +1949.7% | 4,175,000 | +19.3% | 0.26% | +1646.7% |
Q1 2021 | $3,591,000 | -4.0% | 3,500,000 | 0.0% | 0.02% | -11.8% |
Q4 2020 | $3,740,000 | +2.0% | 3,500,000 | 0.0% | 0.02% | -19.0% |
Q3 2020 | $3,668,000 | -14.4% | 3,500,000 | 0.0% | 0.02% | -27.6% |
Q2 2020 | $4,285,000 | +18.1% | 3,500,000 | 0.0% | 0.03% | -6.5% |
Q1 2020 | $3,628,000 | -1.7% | 3,500,000 | 0.0% | 0.03% | +24.0% |
Q4 2019 | $3,690,000 | +6.4% | 3,500,000 | 0.0% | 0.02% | -7.4% |
Q3 2019 | $3,467,000 | -4.3% | 3,500,000 | 0.0% | 0.03% | -10.0% |
Q2 2019 | $3,624,000 | +1.3% | 3,500,000 | 0.0% | 0.03% | 0.0% |
Q1 2019 | $3,576,000 | – | 3,500,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SHENKMAN CAPITAL MANAGEMENT INC | 25,130,000 | $26,845,000 | 3.25% |
ZAZOVE ASSOCIATES LLC | 33,935,000 | $35,929,000 | 3.11% |
Cheyne Capital Management (UK) LLP | 3,000,000 | $3,179,000 | 1.89% |
ADVENT CAPITAL MANAGEMENT /DE/ | 73,250,000 | $77,604,000 | 1.60% |
Sonora Investment Management, LLC | 7,390,000 | $7,792,000 | 1.08% |
Lombard Odier Asset Management (Europe) Ltd | 11,613,000 | $12,391,000 | 0.86% |
SSI INVESTMENT MANAGEMENT LLC | 6,083,000 | $6,421,000 | 0.50% |
MACKAY SHIELDS LLC | 53,388,000 | $57,017,000 | 0.44% |
OAKTREE CAPITAL MANAGEMENT LP | 18,865,000 | $20,150,000 | 0.27% |
LOOMIS SAYLES & CO L P | 907,254 | $120,544,000 | 0.24% |